In the BioHarmony Drug Report Database
Doxepin
Doxepin, Silenor, Sinequan, Zonalon (doxepin) is a small molecule pharmaceutical. Doxepin was first approved as Doxepin on 1982-01-01. It is used to treat anxiety disorders, atopic dermatitis, depressive disorder, pain, and pruritus amongst others in the USA. The pharmaceutical is active against sodium-dependent serotonin transporter and sodium-dependent noradrenaline transporter. In addition, it is known to target histamine H1 receptor. Doxepin hydrochloride’s patents are valid until 2030-09-07 (FDA).
Trade Name
|
Doxepin, Silenor, Sinequan, Zonalon |
|---|---|
Common Name
|
doxepin |
ChEMBL ID
|
CHEMBL1628227 |
Indication
|
anxiety disorders, atopic dermatitis, depressive disorder, pain, pruritus, psychotic affective disorders |
Drug Class
|
Tricyclic compounds |
Image (chem structure or protein)